McCarty TR, et al. - Investigators estimated the data to analyze the efficacy and safety of radiofrequency ablation (RFA) and argon plasma coagulation (APC) in the treatment of gastric antral vascular ectasia (GAVE). They observed significantly longer pooled mean follow-up for APC as compared with RFA (19.52±13.11 vs 7.43±3.72 mo). They noticed 47% of RFA patients refractory to prior treatment with APC. They recorded the demand for fewer mean treatment sessions among RFA cases when compared with APC (2.10 vs 3.39). They noted higher posttreatment pooled hemoglobin increase and reduction in transfusion dependence for APC vs RFA [weighted mean difference 3.10 g/dL vs 1.95 g/dL; and 88% vs 66%; for APC and RFA, respectively]. However, the reported endoscopic success was better with RFA vs APC (97% vs 66%).